Frontline treatment approaches in TP53-aberrant mantle cell lymphoma.
Shah NN, Castillo-Tokumori F, Whiting J, Boulware D, Sandoval-Sus J, Knepper TC, Hussaini M, Tao J, Chavez JC, Isenalumhe L, Gaballa S, Saeed H, Bello C, Sokol L, Pinilla-Ibarz J, Shah BD.
Shah NN, et al. Among authors: castillo tokumori f.
Leuk Lymphoma. 2023 Jan;64(1):230-233. doi: 10.1080/10428194.2022.2131407. Epub 2022 Oct 27.
Leuk Lymphoma. 2023.
PMID: 36301721
No abstract available.